Science Explorer Interactive view Map
Hospital / health system · New York · ??

Tisch Cancer Institute

World rank, all time
#18,486
of 42,892
Rank in ??
#268
of 1,041
Research works
156
▲ 91% vs 2013–17
Citations
5.8k
37.0 per fractional work
Top-10% rate
20.8%
record average 16.5%
Open access
50%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.05× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.65× its world share, 9 worksBiochemistry, Geneti…Immunology and Microbiology: 5.37× its world share, 2 worksImmunology and Micro…Neuroscience: 0.93× its world share, 1 worksNeuroscienceChemistry: 0.19× its world share, 0 worksChemistryComputer Science: 0.01× its world share, 0 worksComputer ScienceEngineering: 0.01× its world share, 0 worksEngineeringEnvironmental Science: 0.02× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.12× its world share, 0 worksMaterials ScienceMathematics: 0.09× its world share, 0 worksMathematicsPhysics and Astronomy: 0.07× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.74× its world share, 1 worksHealth ProfessionsMedicine: 3.54× its world share, 30 worksMedicineNursing: 0.76× its world share, 0 worksNursingDecision Sciences: 0.06× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.39× its world share, 0 worksEconomics, Econometr…Psychology: 0.16× its world share, 0 worksPsychologySocial Sciences: 0.01× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Immunology and Microbiology, 5.4×. Every wedge is a field page.

Which keywords describe research at Tisch Cancer Institute?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Immunotherapy, Targeted Therapy, Cancer, Clinical Trials, Radiotherapy, Tumor Microenvironment and Cancer Immunotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy5▲ 17×15 topics
  2. Immunotherapy5▲ 16×13 topics
  3. Cancer4▲ 6.4×22 topics
  4. Targeted Therapy4▲ 38×5 topics
  5. Clinical Trials3▲ 11×7 topics
  6. Radiotherapy3▲ 19×8 topics
  7. Tumor Microenvironment3▲ 15×6 topics
  8. Cancer Immunotherapy3▲ 43×2 topics
  9. Breast Cancer3▲ 26×8 topics
  10. Prognostic Factors3▲ 15×8 topics
  11. Gene Expression3▲ 9.6×8 topics
  12. Lymphoma3▲ 37×3 topics
  13. Neoadjuvant Therapy2▲ 24×4 topics
  14. Proteasome Inhibitors2▲ 74×2 topics
  15. Minimal Residual Disease2▲ 73×2 topics
  16. Staging System2▲ 76×2 topics
  17. Tumor Regression2▲ 42×2 topics
  18. Diagnosis Criteria2▲ 130×1 topic
  19. International Myeloma Working Group2▲ 130×1 topic
  20. Leukemia2▲ 53×2 topics
  21. CAR T Cells2▲ 56×1 topic
  22. Chimeric Antigen Receptor2▲ 56×1 topic
  23. Genomic Profiling2▲ 40×2 topics
  24. Immunity2▲ 10×5 topics
  25. Clinical Practice Guidelines2▲ 7.1×5 topics
  26. ALK Inhibitors2▲ 58×1 topic
  27. Biomarkers2▲ 5.3×6 topics
  28. EGFR Mutations2▲ 58×1 topic
  29. Genomic Instability2▲ 32×2 topics
  30. Immune Checkpoint Blockade2▲ 33×1 topic
  31. PD-1 and PD-L12▲ 33×1 topic
  32. Cancer Therapy2▲ 6.0×9 topics
  33. Metastatic Breast Cancer2▲ 58×2 topics
  34. Antigen Presentation1▲ 35×2 topics
  35. Cancer Genomics1▲ 43×1 topic
  36. Molecular Characterization1▲ 17×5 topics
  37. Molecular Subtypes1▲ 38×2 topics
  38. Mutational Signatures1▲ 43×1 topic
  39. Survival1▲ 23×3 topics
  40. Survival Analysis1▲ 11×5 topics

Which research topics does Tisch Cancer Institute publish most on?

By volume in 2022–2025: Multiple Myeloma Research and Treatments, CAR-T cell therapy research, Lung Cancer Treatments and Mutations and Cancer Immunotherapy and Biomarkers.

  1. 1 Multiple Myeloma Research and Treatments Hematology 2 works
  2. 2 CAR-T cell therapy research Oncology 2 works
  3. 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
  4. 4 Cancer Immunotherapy and Biomarkers Oncology 2 works
  5. 5 Cancer Genomics and Diagnostics Cancer Research 1 works
  6. 6 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
  7. 7 Breast Cancer Treatment Studies Cancer Research 1 works
  8. 8 Immunotherapy and Immune Responses Immunology 1 works
  9. 9 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 1 works
  10. 10 Bladder and Urothelial Cancer Treatments Surgery 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available49.6%not open50.4%

World: 28% of research is openly available.

with international co-authors37.9%domestic only62.1%

World: 19% is written across borders.

How has Tisch Cancer Institute's research output changed?

Output in 2018–2022 was 91% higher than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in New York

All research institutions in New York

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.